Daniela Drago

447 total citations
20 papers, 330 citations indexed

About

Daniela Drago is a scholar working on Organic Chemistry, Inorganic Chemistry and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Daniela Drago has authored 20 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Organic Chemistry, 7 papers in Inorganic Chemistry and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Daniela Drago's work include Asymmetric Hydrogenation and Catalysis (7 papers), Organometallic Complex Synthesis and Catalysis (7 papers) and Biomedical Ethics and Regulation (4 papers). Daniela Drago is often cited by papers focused on Asymmetric Hydrogenation and Catalysis (7 papers), Organometallic Complex Synthesis and Catalysis (7 papers) and Biomedical Ethics and Regulation (4 papers). Daniela Drago collaborates with scholars based in United States, Switzerland and Slovakia. Daniela Drago's co-authors include Paul S. Pregosin, Andreas Pfaltz, T.J. Geldbach, Paige McDonald, Karen S. Schlumpf, Kenneth J. Harwood, Abbas Razavi, Robert G. Pietrusko, Keith Wonnacott and Carmela Grazia Arena and has published in prestigious journals such as Chemical Communications, Molecular Therapy and Organometallics.

In The Last Decade

Daniela Drago

20 papers receiving 318 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniela Drago United States 12 188 158 48 37 31 20 330
Debra Willison United Kingdom 9 204 1.1× 55 0.3× 18 0.4× 77 2.1× 24 0.8× 16 345
Bryan Chan United States 10 149 0.8× 21 0.1× 109 2.3× 16 0.4× 15 0.5× 12 317
Amy M. Shachter United States 10 148 0.8× 112 0.7× 73 1.5× 29 0.8× 30 1.0× 13 410
Michael M. King United States 9 244 1.3× 105 0.7× 150 3.1× 7 0.2× 14 0.5× 17 486
N.O. Iskeleli Türkiye 13 302 1.6× 114 0.7× 39 0.8× 14 0.4× 134 4.3× 50 441
John D. Weaver United States 9 254 1.4× 78 0.5× 218 4.5× 7 0.2× 19 0.6× 21 447
Olivier Brigaud France 5 88 0.5× 163 1.0× 94 2.0× 18 0.5× 16 0.5× 6 378
Kevin Gillespie United Kingdom 14 624 3.3× 298 1.9× 64 1.3× 5 0.1× 30 1.0× 17 731
James G. Goll Germany 11 93 0.5× 75 0.5× 58 1.2× 25 0.7× 68 2.2× 21 366
Kimberly B. Fields United States 13 296 1.6× 120 0.8× 63 1.3× 129 3.5× 9 0.3× 19 605

Countries citing papers authored by Daniela Drago

Since Specialization
Citations

This map shows the geographic impact of Daniela Drago's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniela Drago with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniela Drago more than expected).

Fields of papers citing papers by Daniela Drago

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniela Drago. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniela Drago. The network helps show where Daniela Drago may publish in the future.

Co-authorship network of co-authors of Daniela Drago

This figure shows the co-authorship network connecting the top 25 collaborators of Daniela Drago. A scholar is included among the top collaborators of Daniela Drago based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniela Drago. Daniela Drago is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Drago, Daniela, et al.. (2023). Clinical holds for cell and gene therapy trials: Risks, impact, and lessons learned. Molecular Therapy — Methods & Clinical Development. 31. 101125–101125. 13 indexed citations
2.
Drago, Daniela, et al.. (2022). Planning for progress: A US regulatory approach to advancing the clinical development of gene therapies. Molecular Therapy. 30(7). 2397–2400. 4 indexed citations
3.
Drago, Daniela, et al.. (2021). Global regulatory progress in delivering on the promise of gene therapies for unmet medical needs. Molecular Therapy — Methods & Clinical Development. 21. 524–529. 21 indexed citations
4.
Bennett, Simon J., et al.. (2020). Regulatory considerations in the development of gene therapies for neurological disorders in the EU region: an industry perspective. Cell and Gene Therapy Insights. 6(5). 877–885. 1 indexed citations
5.
Jordan, John B., et al.. (2019). Current state of biologic pharmacovigilance in the European Union: improvements are needed. Expert Opinion on Drug Safety. 18(3). 231–240. 16 indexed citations
6.
Harwood, Kenneth J., et al.. (2018). Comparing student outcomes in traditional vs intensive, online graduate programs in health professional education. BMC Medical Education. 18(1). 240–240. 34 indexed citations
7.
Drago, Daniela, Paige McDonald, & Gaetano R. Lotrecchiano. (2018). Communicating Transdisciplinary Characteristics In Global Regulatory Affairs: An Example From Health Professions Education. Informing Science The International Journal of an Emerging Transdiscipline. 21. 219–234. 2 indexed citations
8.
McDonald, Paige, et al.. (2017). Design for success: Identifying a process for transitioning to an intensive online course delivery model in health professions education. Medical Education Online. 23(1). 1415617–1415617. 15 indexed citations
9.
Drago, Daniela, et al.. (2016). Improving Regulatory Education: Can We Reconcile Employers’ Expectations With Academic Offerings?. Therapeutic Innovation & Regulatory Science. 50(3). 330–336. 4 indexed citations
10.
Drago, Daniela, et al.. (2016). Increasing the odds of effective drug development: Elevating regulatory affairs professionals to strategic partners. Clinical Research and Regulatory Affairs. 33(2-4). 59–65. 3 indexed citations
11.
12.
Drago, Daniela & Paul S. Pregosin. (2002). Palladium−Duphos Structural and Enantioselective Hydroarylation Chemistry. Organometallics. 21(6). 1208–1215. 42 indexed citations
13.
Geldbach, T.J., Daniela Drago, & Paul S. Pregosin. (2002). A weak η1 π-bonding mode for Ruarene complexes. Nitrile, isonitrile and phosphine derivatives of Ruphosphinoarene chelating complexes. Journal of Organometallic Chemistry. 643-644. 214–222. 23 indexed citations
14.
Drago, Daniela, et al.. (2001). Ruthenium(II)−MeO−Biphep−Arene Dications:  Acetylene Reactions and Unexpected Cyclometalation. Organometallics. 20(14). 2982–2989. 19 indexed citations
15.
16.
Drago, Daniela & Paul S. Pregosin. (2000). Allyl, olefin, aryl and alkyl organometallic palladium complexes of 1,2-bis[(2R,5R)-2,5-dimethylphospholanyl]benzene. Journal of the Chemical Society Dalton Transactions. 3191–3196. 21 indexed citations
17.
Drago, Daniela, Paul S. Pregosin, & Abbas Razavi. (2000). 13C NMR Studies on Zr(ansa-Fluorenyl) Complexes. Molecules with Flexible Bonding Modes. Organometallics. 19(9). 1802–1805. 14 indexed citations
18.
Drago, Daniela, et al.. (1999). Structural distortions in Pd–MeO-Biphep and Pd–Binap aryl complexes. Anomalies induced via electronic effects. Journal of the Chemical Society Dalton Transactions. 2279–2280. 9 indexed citations
19.
Arena, Carmela Grazia, et al.. (1999). Diphosphinito-bridged ruthenium(II) and rhodium(III) complexes with stereogenic metal centers. Inorganica Chimica Acta. 292(1). 84–95. 6 indexed citations
20.
Arena, Carmela Grazia, Daniela Drago, & Felice Faraone. (1999). Hydroformylation of styrene and 1-octene catalyzed by binuclear and oligomer rhodium(I) complexes containing the bis-p-phosphinito ligands [(p-Ph2POC6H4)2X] (X=O, CMe2, S). Journal of Molecular Catalysis A Chemical. 144(3). 379–388. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Debra Willison Breakdown of academic impact, for papers by Bryan Chan Breakdown of academic impact, for papers by Amy M. Shachter Breakdown of academic impact, for papers by Michael M. King Breakdown of academic impact, for papers by N.O. Iskeleli Breakdown of academic impact, for papers by John D. Weaver Breakdown of academic impact, for papers by Olivier Brigaud Breakdown of academic impact, for papers by Kevin Gillespie Breakdown of academic impact, for papers by James G. Goll Breakdown of academic impact, for papers by Kimberly B. Fields
Rankless by CCL
2026